Chief Business Officer
Parithera
The startup specializes in precision oncology by employing targeted therapies and immunotherapies tailored to the genetic profiles of individual tumors. This method enhances treatment efficacy while reducing side effects for various cancer types.
- Biotechnology
Updated 23 months ago
Funding
Raised to date
$100KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup specializes in precision oncology by employing targeted therapies and immunotherapies tailored to the genetic profiles of individual tumors. This method enhances treatment efficacy while reducing side effects for various cancer types.